107 related articles for article (PubMed ID: 12096347)
1. Frequent mutations of Fas gene in nasal NK/T cell lymphoma.
Takakuwa T; Dong Z; Nakatsuka S; Kojya S; Harabuchi Y; Yang WI; Nagata S; Aozasa K
Oncogene; 2002 Jul; 21(30):4702-5. PubMed ID: 12096347
[TBL] [Abstract][Full Text] [Related]
2. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
[TBL] [Abstract][Full Text] [Related]
3. Frequent mutations of Fas gene in thyroid lymphoma.
Takakuwa T; Dong Z; Takayama H; Matsuzuka F; Nagata S; Aozasa K
Cancer Res; 2001 Feb; 61(4):1382-5. PubMed ID: 11245438
[TBL] [Abstract][Full Text] [Related]
4. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.
Lee SH; Shin MS; Park WS; Kim SY; Kim HS; Han JY; Park GS; Dong SM; Pi JH; Kim CS; Kim SH; Lee JY; Yoo NJ
Oncogene; 1999 Jun; 18(25):3754-60. PubMed ID: 10391683
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
7. Fas gene mutations in mycosis fungoides: analysis of laser capture-microdissected specimens from cutaneous lesions.
Nagasawa T; Takakuwa T; Takayama H; Dong Z; Miyagawa S; Itami S; Yoshikawa K; Aozasa K
Oncology; 2004; 67(2):130-4. PubMed ID: 15539917
[TBL] [Abstract][Full Text] [Related]
8. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
9. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
10. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
[TBL] [Abstract][Full Text] [Related]
11. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder.
Lee SH; Shin MS; Park WS; Kim SY; Dong SM; Pi JH; Lee HK; Kim HS; Jang JJ; Kim CS; Kim SH; Lee JY; Yoo NJ
Cancer Res; 1999 Jul; 59(13):3068-72. PubMed ID: 10397246
[TBL] [Abstract][Full Text] [Related]
12. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
Takahara M; Kishibe K; Bandoh N; Nonaka S; Harabuchi Y
Hum Pathol; 2004 Jan; 35(1):86-95. PubMed ID: 14745729
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
14. [Expression profile of nasal NK/T cell lymphoma by cDNA microarray].
Wang WH; Li YX; Lin C; Liu XF; Yu ZH; Song YW; Zhang XY; Fu M; Jin J; Wang SL; Liu YP
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):518-22. PubMed ID: 17147117
[TBL] [Abstract][Full Text] [Related]
15. p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan.
Hongyo T; Hoshida Y; Nakatsuka S; Syaifudin M; Kojya S; Yang WI; Min YH; Chan H; Kim CH; Harabuchi Y; Himi T; Inuyama M; Aozasa K; Nomura T
Oncol Rep; 2005 Feb; 13(2):265-71. PubMed ID: 15643509
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of anti-fas ribozyme on apoptosis of mouse T cells.
Zhang M; Chen ZC; Tian L; Liu F; Liu LB; You Y; Zou P
Ai Zheng; 2005 May; 24(5):520-4. PubMed ID: 15890090
[TBL] [Abstract][Full Text] [Related]
17. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
Li T; Zhang B; Ye Y; Yin H
Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
[TBL] [Abstract][Full Text] [Related]
19. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
[TBL] [Abstract][Full Text] [Related]
20. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma.
Shin MS; Park WS; Kim SY; Kim HS; Kang SJ; Song KY; Park JY; Dong SM; Pi JH; Oh RR; Lee JY; Yoo NJ; Lee SH
Am J Pathol; 1999 Jun; 154(6):1785-91. PubMed ID: 10362803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
